Clinical Trial

Pharmacokinetics of Medication for Severe Ulcerative Colitis

Study Description

Pharmacokinetics of IFX and TNF Concentrations in Serum, Stool, and Colonic Mucosa in Acute Severe Ulcerative Colitis

This is an open-label, prospective, observational study with the primary objective to characterize the pharmacokinetics of infliximab in patients with Acute Severe Ulcerative Colitis.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Recruiting patients only Recruiting patients only

Drug - Infliximab

Patients will receive infliximab at the discretion of their physician as part of standard of care.

Additional Information

Official Study Title

Pharmacokinetics of Infliximab and Tumor Necrosis Factor Concentrations in Serum, Stool, and Colonic Mucosa in Acute Severe Ulcerative Colitis

Clinical Trial ID

NCT03765450

ParticipAid ID

dNk5Le